Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

crawled date : 2022 - 10 - 05    crawled time : 17:00    save search

Lantern Pharma to Present at Upcoming Investor Conferences
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K twitter stocktwits trandingview |
Health Technology
| | O: 1.23% H: 2.02% C: -1.01%

pharma
Adicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 1.19% C: 0.2%

preclinical immunotherapy meeting cancer
Twist Bioscience to Present at JSNN NanoImpacts 2022
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -3.18% H: 2.45% C: 1.32%

bioscience
Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
COCP | $1.495 -1.39% 7.6K twitter stocktwits trandingview |
Health Technology
| | O: 1.78% H: 2.54% C: -1.44%

pharma conference growth
I-Mab Announces Poster Presentations of CD47 Antibody Lemzoparlimab and CD73 Antibody Uliledlimab at SITC 2022
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
IMAB | $1.81 0.56% 0.55% 340K twitter stocktwits trandingview |
Health Technology
| | O: -1.22% H: 2.67% C: -2.48%

cd47 antibody cd73
Thermo Fisher Scientific Announces New Cryo-TEM with Expansive Automation Features to Help Accelerate Drug Discovery Research
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
TMO | News | $544.78 0.6% 0.0% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.02% H: 0.0% C: 0.0%

drug research
Oncolytics Biotech® Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K twitter stocktwits trandingview |
Health Technology
| | O: 0.77% H: 0.76% C: -3.05%

biotech immunotherapy meeting cancer
AbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K twitter stocktwits trandingview |
| | O: -2.14% H: 3.64% C: 2.09%

t-cell presentation platform
Leap Therapeutics to Present Updated Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab and Preclinical Data in Colorectal Cancer Models at the SITC Annual Meeting
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
LPTX | $2.81 -5.07% -5.34% 200K twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 0.39% C: -2.49%
BGNE | $129.51 -1.86% -1.89% 300K twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.08% C: -0.29%

dkn-01 preclinical meeting therapeutics plus leap cancer study
U.S. Food and Drug Administration Accepts Takeda’s Supplemental Biologics License Application for Use of TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.47% H: 0.9% C: 0.37%

takhzyro drug children application license food hereditary angioedema
Eiger BioPharmaceuticals Provides Update on Plans for Emergency Use Authorization Application Following FDA Feedback
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
EIGR | $1.725 -1.45% 140K twitter stocktwits trandingview |
Health Technology
| | O: -6.36% H: 4.05% C: 1.45%

fda application authorization update
IRIS Software Group Consolidates Data from Schools in a Central Platform Powered by Snowflake
Published: 2022-10-05 (Crawled : 17:00) - snowflake.com
SNOW | News | $145.45 -1.99% -0.08% 5M twitter stocktwits trandingview |
Technology Services
| | O: -1.79% H: 3.33% C: 2.68%

software platform group
Yield10 Bioscience Appoints Willie Loh, Ph.D., Former Cargill Executive, to the Board of Directors
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
YTEN | $0.252 -7.59% -8.21% 280K twitter stocktwits trandingview |
Health Technology
| | O: 0.83% H: 3.8% C: -1.49%

bioscience
ooma-telo-leadform-module-w-phone-cta
Published: 2022-10-05 (Crawled : 17:00) - ooma.com
OOMA 4 | $7.06 0.57% 0.0% 110K twitter stocktwits trandingview |
Technology Services
| | O: -0.83% H: 1.15% C: 0.99%


Q3 – TRANSPORTER
Published: 2022-10-05 (Crawled : 17:00) - marten.com
MRTN | $16.57 3.76% 3.62% 1.3M twitter stocktwits trandingview |
Transportation
| | O: -0.84% H: 1.35% C: 0.15%


Fortress Biotech Announces Timing of Regular Monthly Dividend for October, November and December 2022 for its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
AZNCF | News | $138.24 -4.19% 800 twitter stocktwits trandingview |
Health Technology
| | O: -1.24% H: 1.81% C: 0.48%
FBIO | $1.765 -2.49% -2.55% 190K twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 4.52% C: 2.06%
AZN | News | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.74% H: 1.53% C: 1.21%

biotech
Agenus to Host “The Road Taken” R&D Event on November 12, 2022
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -2.26% H: 11.34% C: 9.72%


Albireo to Showcase New Data at AASLD The Liver Meeting® 2022
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
ALBO | $44.15 -0.23% 0.39% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 2.35% H: 4.74% C: 4.48%

meeting liver
Xencor to Present Seven Posters on Multiple Clinical Trials and Research-stage Programs at the SITC Annual Meeting
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K twitter stocktwits trandingview |
Health Technology
| | O: -1.31% H: 1.13% C: 0.68%

trials meeting
Poseida Therapeutics to Present Trial in Progress Poster for Phase 1 P-MUC1C-ALLO1 Study at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
PSTX | $2.02 1.0% 0.99% 640K twitter stocktwits trandingview |
Health Technology
| | O: -1.14% H: 8.38% C: 7.51%

immunotherapy meeting trial therapeutics cancer study phase 1
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.